Vadood Javadi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Vadood Javadi has a total of 49 co-authors. Here are the top co-authors by number of shared publications:
- Khosro Rahmani
Department of Pediatric Rheumatology, Faculty of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran
13 shared publications - Reza Shiari
Department of Pediatric Rheumatology, Mofid Children's Hospital Shahid Beheshti University of Medical Sciences Tehran Iran
13 shared publications Khosro Rahmani
Department of Rheumatology, Mofid Children's Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran
9 shared publicationsReza Shiari
Department of Rheumatology, Mofid Children's Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran
6 shared publications- Ghazal Zahed
Shahid School of Medicine Beheshti University of Medical Sciences Shaheed Beheshti University of Medical Sciences Shaheed Beheshti University of Medical Sciences Shaheed Beheshti University of Medical Sciences
3 shared publications - Mehrnoush Hassas Yeganeh
Shahid Beheshti University of Medical Sciences, Tehran, Iran
3 shared publications
Latest Publications
- Open Access
- 29 May 2026
- Published by Springer Nature in BMC Rheumatology
- Vol. 10 (1)
Effects of a cow’s milk protein–free diet as an adjunct to standard therapy in juvenile idiopathic arthritis: a randomized controlled study
Juvenile idiopathic arthritis (JIA) is a chronic autoimmune disorder, characterized by chronic idiopathic joint inflammation in children under sixteen years of age. Emerging evidence suggests that food allergens- particularly cow's milk proteins may modulate inflammatory pathways, and that their elimination could potentially ameliorate disease activity. This study aimed to evaluate through a randomized controlled clinical trial whether eliminating cow's milk protein from the diet influences disease activity and symptom severity in children with JIA. In this randomized controlled trial, 120 children with controlled juvenile idiopathic arthritis (JIA) receiving stable standard therapy were randomly allocated to either a cow's milk protein-free diet (intervention group, n = 60) or an unrestricted diet (control group, n = 60) for one month. Disease activity was assessed at baseline and post-intervention using subjective measures (patient- and physician-reported Visual Analog Scale [VAS]) and objective parameters, including erythrocyte sedimentation rate (ESR), C-reactive protein (CRP), active joint count, morning stiffness duration, fever. Compared with baseline, the intervention group demonstrated statistically significant improvements in multiple outcomes, including patient VAS (2.9 ± 1.9 to 1.7 ± 1.4; P < 0.001), physician VAS (2.5 ± 1.8 to 1.6 ± 1.3; P < 0.001), ESR (14.6 ± 13.7 to 9.4 ± 7.3 mm/hr; P < 0.001), CRP (7.3 ± 13.7 to 2.5 ± 3.6 mg/dL; P = 0.011), morning stiffness duration (6.1 to 0.6 min; P = 0.002), active joint count (0.55 to 0.11; P < 0.001), and Disease Activity Score (5.53 ± 4.44 to 3.0 ± 2.6; P < 0.001). In contrast, the control group exhibited only minor or non-significant changes. In children with well-controlled JIA, a cow's milk protein-free diet was associated with modest short-term improvements in pain and disease activity. These findings suggest a potential adjunctive benefit alongside standard therapy, but the short duration, low baseline disease activity, and reliance on parental self-report warrant cautious interpretation. The protocol of this clinical trial has been registered in the Iranian Clinical Trial Registration Center (registration code: IRCT20241230064216N1). Registered 28 April 2025, available from https://irct.behdasht.gov.ir/search/result?query=IRCT20241230064216N1, and ethical approval was obtained from the Ethics Committee of Shahid Beheshti University of Medical Sciences, registered 10 November 2024 (Ethics Code: IR.SBMU.MAP.REC.1403.531).
- 29 May 2026
- Published by Springer Nature in BMC Rheumatology
- Vol. 10 (1)
Open AccessEffects of a cow’s milk protein–free diet as an adjunct to standard therapy in juvenile idiopathic arthritis: a randomized controlled study
Juvenile idiopathic arthritis (JIA) is a chronic autoimmune disorder, characterized by chronic idiopathic joint inflammation in children under sixteen years of age. Emerging evidence suggests that food allergens- particularly cow's milk proteins may modulate inflammatory pathways, and that their elimination could potentially ameliorate disease activity. This study aimed to evaluate through a randomized controlled clinical trial whether eliminating cow's milk protein from the diet influences disease activity and symptom severity in children with JIA. In this randomized controlled trial, 120 children with controlled juvenile idiopathic arthritis (JIA) receiving stable standard therapy were randomly allocated to either a cow's milk protein-free diet (intervention group, n = 60) or an unrestricted diet (control group, n = 60) for one month. Disease activity was assessed at baseline and post-intervention using subjective measures (patient- and physician-reported Visual Analog Scale [VAS]) and objective parameters, including erythrocyte sedimentation rate (ESR), C-reactive protein (CRP), active joint count, morning stiffness duration, fever. Compared with baseline, the intervention group demonstrated statistically significant improvements in multiple outcomes, including patient VAS (2.9 ± 1.9 to 1.7 ± 1.4; P < 0.001), physician VAS (2.5 ± 1.8 to 1.6 ± 1.3; P < 0.001), ESR (14.6 ± 13.7 to 9.4 ± 7.3 mm/hr; P < 0.001), CRP (7.3 ± 13.7 to 2.5 ± 3.6 mg/dL; P = 0.011), morning stiffness duration (6.1 to 0.6 min; P = 0.002), active joint count (0.55 to 0.11; P < 0.001), and Disease Activity Score (5.53 ± 4.44 to 3.0 ± 2.6; P < 0.001). In contrast, the control group exhibited only minor or non-significant changes. In children with well-controlled JIA, a cow's milk protein-free diet was associated with modest short-term improvements in pain and disease activity. These findings suggest a potential adjunctive benefit alongside standard therapy, but the short duration, low baseline disease activity, and reliance on parental self-report warrant cautious interpretation. The protocol of this clinical trial has been registered in the Iranian Clinical Trial Registration Center (registration code: IRCT20241230064216N1). Registered 28 April 2025, available from https://irct.behdasht.gov.ir/search/result?query=IRCT20241230064216N1, and ethical approval was obtained from the Ethics Committee of Shahid Beheshti University of Medical Sciences, registered 10 November 2024 (Ethics Code: IR.SBMU.MAP.REC.1403.531).
- Open Access
- 1 January 2026
- Vol. 20 (1) , 1-7
Metabolic-Immune Crosstalk in Pediatric Rheumatology: From Pathogenesis to Precision Therapy
The immune system and metabolic pathways are strongly interconnected, influencing each other in both physiological and pathological contexts. Nutrient signaling and cellular energy levels significantly impact immune system function, from activation to differentiation and survival. In children, where both the immune and metabolic systems are still developing, disturbances in this balance can markedly influence disease manifestation and treatment response. Recent advances in immunometabolism have revealed that metabolic dysfunction is not merely a consequence of inflammation but can also serve as a primary driver of immune dysregulation. Accordingly, this review explores how metabolic disturbances may mimic or modify rheumatic diseases, and, conversely, how immune-mediated disorders can disrupt metabolic homeostasis. Understanding this bidirectional relationship provides novel insights into pathogenesis and opens avenues for metabolism-based diagnostic and therapeutic strategies in pediatric rheumatology.
- 1 January 2026
- Vol. 20 (1) , 1-7
Open AccessMetabolic-Immune Crosstalk in Pediatric Rheumatology: From Pathogenesis to Precision Therapy
The immune system and metabolic pathways are strongly interconnected, influencing each other in both physiological and pathological contexts. Nutrient signaling and cellular energy levels significantly impact immune system function, from activation to differentiation and survival. In children, where both the immune and metabolic systems are still developing, disturbances in this balance can markedly influence disease manifestation and treatment response. Recent advances in immunometabolism have revealed that metabolic dysfunction is not merely a consequence of inflammation but can also serve as a primary driver of immune dysregulation. Accordingly, this review explores how metabolic disturbances may mimic or modify rheumatic diseases, and, conversely, how immune-mediated disorders can disrupt metabolic homeostasis. Understanding this bidirectional relationship provides novel insights into pathogenesis and opens avenues for metabolism-based diagnostic and therapeutic strategies in pediatric rheumatology.
- Open Access
- 29 December 2025
- Published by IntechOpen
Juvenile Idiopathic Arthritis
Juvenile idiopathic arthritis (JIA), previously known as juvenile rheumatoid arthritis, is the most common form of rheumatic disease in children under the age of 16. It is characterized by chronic joint inflammation of unknown origin. JIA is classified into several types based on the number of joints affected and other clinical characteristics, with the International League of Associations for Rheumatology criteria being the most widely recognized classification system. The primary types include oligoarticular JIA, which affects four or fewer joints; polyarticular JIA, impacting five or more joints; psoriatic arthritis; enthesitis-related arthritis; systemic-onset JIA; and undifferentiated arthritis. JIA typically presents with joint pain, swelling, and stiffness. It may also include systemic symptoms such as fever and fatigue, particularly in cases of systemic-onset JIA (2). Common complications can include growth abnormalities, joint contractures, and osteoporosis. Imaging techniques such as X-rays, magnetic resonance imaging, and ultrasounds are crucial for assessing joint involvement and monitoring disease progression. Managing JIA requires a multidisciplinary approach. This includes pharmacological treatments such as nonsteroidal anti-inflammatory drugs, corticosteroids, disease-modifying antirheumatic drugs, and physical therapy to enhance mobility and quality of life (3). Early diagnosis and treatment are essential for improving long-term outcomes, particularly for polyarticular and rheumatoid factor-positive subtypes, which tend to have a worse prognosis (4).
- 29 December 2025
- Published by IntechOpen
Open AccessJuvenile Idiopathic Arthritis
Juvenile idiopathic arthritis (JIA), previously known as juvenile rheumatoid arthritis, is the most common form of rheumatic disease in children under the age of 16. It is characterized by chronic joint inflammation of unknown origin. JIA is classified into several types based on the number of joints affected and other clinical characteristics, with the International League of Associations for Rheumatology criteria being the most widely recognized classification system. The primary types include oligoarticular JIA, which affects four or fewer joints; polyarticular JIA, impacting five or more joints; psoriatic arthritis; enthesitis-related arthritis; systemic-onset JIA; and undifferentiated arthritis. JIA typically presents with joint pain, swelling, and stiffness. It may also include systemic symptoms such as fever and fatigue, particularly in cases of systemic-onset JIA (2). Common complications can include growth abnormalities, joint contractures, and osteoporosis. Imaging techniques such as X-rays, magnetic resonance imaging, and ultrasounds are crucial for assessing joint involvement and monitoring disease progression. Managing JIA requires a multidisciplinary approach. This includes pharmacological treatments such as nonsteroidal anti-inflammatory drugs, corticosteroids, disease-modifying antirheumatic drugs, and physical therapy to enhance mobility and quality of life (3). Early diagnosis and treatment are essential for improving long-term outcomes, particularly for polyarticular and rheumatoid factor-positive subtypes, which tend to have a worse prognosis (4).
- Open Access
- 19 August 2025
- Published by Springer Nature in BMC Musculoskeletal Disorders
- Vol. 26 (1) , 1-5
Juvenile idiopathic arthritis or skeletal dysplasia: first case report of camptodactyly-arthropathy-coxa vara-pericarditis from Iran
Camptodactyly-arthropathy-coxa vara-pericarditis (CACP) syndrome is an inherited autosomal recessive disorder resulting from a mutation in the PRG4 gene located on chromosome one. This mutation leads to either a deficiency or dysfunction of a glycoprotein known as lubricin, which plays a crucial role in inhibiting synovial inflammation and lubricating synovial joints and visceral cavities. CACP syndrome is characterized by a tetrad of manifestations, including congenital or early-onset camptodactyly, childhood-onset non-inflammatory arthropathy accompanied by synovial hyperplasia, coxa vara deformity, and non-inflammatory pericardial effusion. This case report details the medical history of a 12-year-old boy diagnosed with CACP syndrome, following the identification of a novel homozygous frameshift variant in the PRG4 gene. The patient first exhibited symptoms at 10 days of age with respiratory distress due to pleural effusion and later underwent pericardiectomy for significant pericardial effusion. At age 2, progressive joint effusion led to an initial diagnosis of juvenile idiopathic arthritis. Despite receiving treatment modalities such as non-steroidal anti-inflammatory drugs (NSAIDs), methotrexate, and corticosteroids, the patient experienced minimal improvement. The persistence of progressive joint manifestations, coupled with a lack of favorable response to treatment, prompted further evaluations, which ultimately confirmed the diagnosis of CACP syndrome. This case illustrates diagnostic challenges and rare early cardiac involvement. It discusses the differential diagnosis from juvenile idiopathic arthritis and skeletal dysplasia, as well as the role of genetic testing in unresolved cases.
- 19 August 2025
- Published by Springer Nature in BMC Musculoskeletal Disorders
- Vol. 26 (1) , 1-5
Open AccessJuvenile idiopathic arthritis or skeletal dysplasia: first case report of camptodactyly-arthropathy-coxa vara-pericarditis from Iran
Camptodactyly-arthropathy-coxa vara-pericarditis (CACP) syndrome is an inherited autosomal recessive disorder resulting from a mutation in the PRG4 gene located on chromosome one. This mutation leads to either a deficiency or dysfunction of a glycoprotein known as lubricin, which plays a crucial role in inhibiting synovial inflammation and lubricating synovial joints and visceral cavities. CACP syndrome is characterized by a tetrad of manifestations, including congenital or early-onset camptodactyly, childhood-onset non-inflammatory arthropathy accompanied by synovial hyperplasia, coxa vara deformity, and non-inflammatory pericardial effusion. This case report details the medical history of a 12-year-old boy diagnosed with CACP syndrome, following the identification of a novel homozygous frameshift variant in the PRG4 gene. The patient first exhibited symptoms at 10 days of age with respiratory distress due to pleural effusion and later underwent pericardiectomy for significant pericardial effusion. At age 2, progressive joint effusion led to an initial diagnosis of juvenile idiopathic arthritis. Despite receiving treatment modalities such as non-steroidal anti-inflammatory drugs (NSAIDs), methotrexate, and corticosteroids, the patient experienced minimal improvement. The persistence of progressive joint manifestations, coupled with a lack of favorable response to treatment, prompted further evaluations, which ultimately confirmed the diagnosis of CACP syndrome. This case illustrates diagnostic challenges and rare early cardiac involvement. It discusses the differential diagnosis from juvenile idiopathic arthritis and skeletal dysplasia, as well as the role of genetic testing in unresolved cases.
- Open Access
- 16 April 2024
- Published by Brieflands in Journal of Comprehensive Pediatrics
- Vol. 15 (3)
Assessment of Gastrointestinal Manifestations and Predictive Factors Associated with Their Occurrence in Kawasaki Disease Patients: A Cross-Sectional Study
Background: Kawasaki disease is an idiopathic febrile systemic vasculitis, recognized as the leading cause of acquired heart disease in pediatric patients. Gastrointestinal manifestations can lead to delayed treatment, underscoring the importance of identifying and predicting factors associated with these manifestations to enable timely intervention. Objectives: The primary objective of this study was to identify the aforementioned factors. Methods: This retrospective study collected demographic information, medical history, physical examination findings, and laboratory results of 359 children suspected of having Kawasaki disease and referred to Mofid Children’s Hospital between 2013 and 2022. The study assessed the frequency of gastrointestinal manifestations and their association with physical examination findings and laboratory data. Results: A total of 359 patients were included in the study, comprising 153 males and 206 females. The mean age of participants was 2.8 ± 2.6 years. Abdominal pain was the most common clinical manifestation, reported in 39% of patients. Elevated levels of aspartate aminotransferase (AST) were observed in 38.1% of patients, while 30.2% showed elevated alanine aminotransferase (ALT) levels, and 10.5% exhibited direct hyperbilirubinemia. Patients with elevated ALT and AST levels had a higher incidence of abdominal pain, nausea/vomiting, and anorexia. Moreover, patients with positive findings of red blood cell (RBC) and white blood cell (WBC) in their stool examination had a higher incidence of fever and abdominal pain. Conclusions: Based on our statistical analysis, elevated AST and ALT levels, hyperbilirubinemia, and positive stool findings of RBC and WBC appear to be predictive factors for gastrointestinal manifestations in Kawasaki disease.
- 16 April 2024
- Published by Brieflands in Journal of Comprehensive Pediatrics
- Vol. 15 (3)
Open AccessAssessment of Gastrointestinal Manifestations and Predictive Factors Associated with Their Occurrence in Kawasaki Disease Patients: A Cross-Sectional Study
Background: Kawasaki disease is an idiopathic febrile systemic vasculitis, recognized as the leading cause of acquired heart disease in pediatric patients. Gastrointestinal manifestations can lead to delayed treatment, underscoring the importance of identifying and predicting factors associated with these manifestations to enable timely intervention. Objectives: The primary objective of this study was to identify the aforementioned factors. Methods: This retrospective study collected demographic information, medical history, physical examination findings, and laboratory results of 359 children suspected of having Kawasaki disease and referred to Mofid Children’s Hospital between 2013 and 2022. The study assessed the frequency of gastrointestinal manifestations and their association with physical examination findings and laboratory data. Results: A total of 359 patients were included in the study, comprising 153 males and 206 females. The mean age of participants was 2.8 ± 2.6 years. Abdominal pain was the most common clinical manifestation, reported in 39% of patients. Elevated levels of aspartate aminotransferase (AST) were observed in 38.1% of patients, while 30.2% showed elevated alanine aminotransferase (ALT) levels, and 10.5% exhibited direct hyperbilirubinemia. Patients with elevated ALT and AST levels had a higher incidence of abdominal pain, nausea/vomiting, and anorexia. Moreover, patients with positive findings of red blood cell (RBC) and white blood cell (WBC) in their stool examination had a higher incidence of fever and abdominal pain. Conclusions: Based on our statistical analysis, elevated AST and ALT levels, hyperbilirubinemia, and positive stool findings of RBC and WBC appear to be predictive factors for gastrointestinal manifestations in Kawasaki disease.
- Open Access
- 18 March 2024
- Published by Brieflands in Journal of Comprehensive Pediatrics
- Vol. 15 (2)
Evaluation of Gastrointestinal Manifestations and Predictive Factors in Pediatric Henoch-Schönlein Purpura
Background: Henoch-Schönlein purpura (HSP) is the most common type of vasculitis in children. Children with HSP often experience gastrointestinal symptoms, such as abdominal pain, nausea/vomiting, gastrointestinal bleeding, and intussusception. These symptoms are estimated to occur in 50 - 75% of cases. Objectives: In this study, we evaluated the prevalence of gastrointestinal manifestations in children with HSP and identified associated predictive factors. Methods: For this cross-sectional study, we collected data from 295 children with HSP, aged 1 to 16, who were treated at Mofid Children's Hospital in Tehran, Iran, between 2013 and 2022. We gathered the following information from hospital records: Laboratory results for ALT, AST, bilirubin, stool exam (S/E), WBC, RBC, and occult blood (OB), as well as demographic data. Clinical symptoms evaluated included fever, rash, abdominal pain, distension, tenderness, nausea/vomiting, diarrhea, anorexia, and icterus. Results: Our study included 295 children diagnosed with HSP, consisting of 46.77% females and 53.23% males. The average age was 5.3 ± 2.8 years for female patients and 6.2 ± 2.9 years for male patients. Further analysis indicated that anorexia was the most common symptom, followed by abdominal pain, diarrhea, nausea/vomiting, and bloody stool. We observed no significant differences in symptoms based on sex. Physical examination findings, including abdominal distension and tenderness, were similar across both sexes. Elevated levels of AST and ALT, as well as hyperbilirubinemia, were noted in some patients. Stool analysis revealed positive results for RBC, WBC, and occult blood in certain cases, with 21% testing positive for RBC, 24.85% for WBC, and 23.25% for occult blood. Anorexia showed a correlation with increased AST levels, while bloody stool was associated with higher ALT levels, hyperbilirubinemia, and direct hyperbilirubinemia. Logistic regression analysis confirmed a significant association between bloody stools and elevated ALT levels. Conclusions: In this study, we examined the clinical manifestations and laboratory findings in children with small vessel vasculitis to identify associated predictive factors. Our findings indicated that anorexia and abdominal pain were the most common clinical manifestations, with bloody stool also being a prevalent symptom. Additionally, logistic regression analysis demonstrated that the presence of bloody stool is a significant predictive factor for elevated ALT levels.
- 18 March 2024
- Published by Brieflands in Journal of Comprehensive Pediatrics
- Vol. 15 (2)
Open AccessEvaluation of Gastrointestinal Manifestations and Predictive Factors in Pediatric Henoch-Schönlein Purpura
Background: Henoch-Schönlein purpura (HSP) is the most common type of vasculitis in children. Children with HSP often experience gastrointestinal symptoms, such as abdominal pain, nausea/vomiting, gastrointestinal bleeding, and intussusception. These symptoms are estimated to occur in 50 - 75% of cases. Objectives: In this study, we evaluated the prevalence of gastrointestinal manifestations in children with HSP and identified associated predictive factors. Methods: For this cross-sectional study, we collected data from 295 children with HSP, aged 1 to 16, who were treated at Mofid Children's Hospital in Tehran, Iran, between 2013 and 2022. We gathered the following information from hospital records: Laboratory results for ALT, AST, bilirubin, stool exam (S/E), WBC, RBC, and occult blood (OB), as well as demographic data. Clinical symptoms evaluated included fever, rash, abdominal pain, distension, tenderness, nausea/vomiting, diarrhea, anorexia, and icterus. Results: Our study included 295 children diagnosed with HSP, consisting of 46.77% females and 53.23% males. The average age was 5.3 ± 2.8 years for female patients and 6.2 ± 2.9 years for male patients. Further analysis indicated that anorexia was the most common symptom, followed by abdominal pain, diarrhea, nausea/vomiting, and bloody stool. We observed no significant differences in symptoms based on sex. Physical examination findings, including abdominal distension and tenderness, were similar across both sexes. Elevated levels of AST and ALT, as well as hyperbilirubinemia, were noted in some patients. Stool analysis revealed positive results for RBC, WBC, and occult blood in certain cases, with 21% testing positive for RBC, 24.85% for WBC, and 23.25% for occult blood. Anorexia showed a correlation with increased AST levels, while bloody stool was associated with higher ALT levels, hyperbilirubinemia, and direct hyperbilirubinemia. Logistic regression analysis confirmed a significant association between bloody stools and elevated ALT levels. Conclusions: In this study, we examined the clinical manifestations and laboratory findings in children with small vessel vasculitis to identify associated predictive factors. Our findings indicated that anorexia and abdominal pain were the most common clinical manifestations, with bloody stool also being a prevalent symptom. Additionally, logistic regression analysis demonstrated that the presence of bloody stool is a significant predictive factor for elevated ALT levels.
- Open Access
- 4 March 2024
- Published by Brieflands in Archives of Pediatric Infectious Diseases
- Vol. 12 (4)
Kawasaki Disease Triggered by Septic Arthritis: A Case Report
: We present the case of a 6.5-year-old boy who presented to our center with complaints of pain in both hip joints that had started 10 days prior to admission. Following the diagnosis and treatment of septic arthritis, he developed a fever that did not respond to antibiotics. Subsequently, he was diagnosed with Kawasaki disease triggered by septic arthritis.
- 4 March 2024
- Published by Brieflands in Archives of Pediatric Infectious Diseases
- Vol. 12 (4)
Open AccessKawasaki Disease Triggered by Septic Arthritis: A Case Report
: We present the case of a 6.5-year-old boy who presented to our center with complaints of pain in both hip joints that had started 10 days prior to admission. Following the diagnosis and treatment of septic arthritis, he developed a fever that did not respond to antibiotics. Subsequently, he was diagnosed with Kawasaki disease triggered by septic arthritis.
- Open Access
- 4 November 2023
- Published by Brieflands in Archives of Pediatric Infectious Diseases
- Vol. 12 (3)
Recurrent Fever and Abdominal Pain: Periodic Fever Syndrome, Inflammatory Bowel Disease or Patent Urachus; A Case Report
Introduction: The urachus is a duct that connects the allantois to the urinary bladder in the fetus. Partial or total obliteration failure of the urachus leads to various anomalies, which can be discovered in children and adults. Case Presentation: A 12-year-old boy presented with recurrent fever and abdominal pain two years ago. In the physical examination, he had tenderness in the lumbosacral area and Achilles tendons. Enthesitis-related arthritis (ERA), inflammatory bowel disease (IBD), and familial Mediterranean fever (FMF) were considered differential diagnoses. The patient was treated with a naproxen anti-inflammatory dose. After 15 months, his mother reported a bad odor discharge from his umbilical area. Investigations revealed patent urachus, and he underwent an operation that confirmed the diagnosis and resolved the patient's complaints.
- 4 November 2023
- Published by Brieflands in Archives of Pediatric Infectious Diseases
- Vol. 12 (3)
Open AccessRecurrent Fever and Abdominal Pain: Periodic Fever Syndrome, Inflammatory Bowel Disease or Patent Urachus; A Case Report
Introduction: The urachus is a duct that connects the allantois to the urinary bladder in the fetus. Partial or total obliteration failure of the urachus leads to various anomalies, which can be discovered in children and adults. Case Presentation: A 12-year-old boy presented with recurrent fever and abdominal pain two years ago. In the physical examination, he had tenderness in the lumbosacral area and Achilles tendons. Enthesitis-related arthritis (ERA), inflammatory bowel disease (IBD), and familial Mediterranean fever (FMF) were considered differential diagnoses. The patient was treated with a naproxen anti-inflammatory dose. After 15 months, his mother reported a bad odor discharge from his umbilical area. Investigations revealed patent urachus, and he underwent an operation that confirmed the diagnosis and resolved the patient's complaints.
- Open Access
- 19 January 2022
- Published by IntechOpen
Juvenile Idiopathic Arthritis
Juvenile idiopathic arthritis (JIA) is the most common form of chronic synovial joint inflammation in children. It potentially leads to disability and psychosocial outcomes for children and their families. In the absence of appropriate treatment, this can lead to joint destruction and disability. Thus, early diagnosis and aggressive treatment are essential. With the presentation of new biologic DMARDs, based on understanding the disease pathophysiology and molecular pathogenesis, the course of the disease and its outcome have been changed profoundly. In this chapter, the early diagnosis, appropriate treatment, and outcomes approaches are described. These include the latest diagnosis and management options.
- 19 January 2022
- Published by IntechOpen
Open AccessJuvenile Idiopathic Arthritis
Juvenile idiopathic arthritis (JIA) is the most common form of chronic synovial joint inflammation in children. It potentially leads to disability and psychosocial outcomes for children and their families. In the absence of appropriate treatment, this can lead to joint destruction and disability. Thus, early diagnosis and aggressive treatment are essential. With the presentation of new biologic DMARDs, based on understanding the disease pathophysiology and molecular pathogenesis, the course of the disease and its outcome have been changed profoundly. In this chapter, the early diagnosis, appropriate treatment, and outcomes approaches are described. These include the latest diagnosis and management options.
- Open Access
- 24 January 2021
- Published by Wiley in Clinical Case Reports
- Vol. 9 (3) , 1354-1357
Pulmonary involvement in brucellosis: A case report and literature review
Although pulmonary involvement is rare in brucellosis it should be considered as a causative agent in patients with prolonged fever and arthritis. Also, it should be presented with manifestations resembling systemic juvenile idiopathic arthritis.
- 24 January 2021
- Published by Wiley in Clinical Case Reports
- Vol. 9 (3) , 1354-1357
Open AccessPulmonary involvement in brucellosis: A case report and literature review
Although pulmonary involvement is rare in brucellosis it should be considered as a causative agent in patients with prolonged fever and arthritis. Also, it should be presented with manifestations resembling systemic juvenile idiopathic arthritis.